JP Morgan lowered the price target for the Medical Properties Trust Inc. (NYSE:MPW) stock from ‘an Overweight’ to ‘a Neutral’. The rating was released on June 22, 2023, according to finviz. We previously noted in another research note published on April 22, 2023 by Jefferies that downgraded the stock from a Buy to a Hold with a price target of $20 for MPW stock. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $21. In their research brief published January 03, 2023, Deutsche Bank analysts downgraded the Medical Properties Trust Inc.